ARTES Biotechnology GmbH
Biotechnological Processes and Products for Today and Tomorrow
ARTES Biotechnology delivers safe, robust and cost efficient protein production based on microbial cell lines including yeast (Hansenula polymorpha, syn. Pichia angusta) and bacteria (E. coli).
Our unique virus like particle (VLP) platform is applied for development of safe and affordable vaccines.
ARTES´ proprietary technologies ensure freedom-to-operate and reliable, competitive production. WHO recommendation, international registration, FDA approval and GRAS certification are part of the track record achieved in our international collaborations.
Large scale manufacturing and full analytics in accordance with cGMP guidelines are warranted in collaboration with a network of industrial partners.
A wide range of processes and products is available in our portfolio for immediate technology transfer.
New cell lines and processes for your product of interest are developed specifically to meet your demands.